These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

746 related articles for article (PubMed ID: 16442629)

  • 1. Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice.
    Giri PK; Verma I; Khuller GK
    J Infect; 2006 Nov; 53(5):350-6. PubMed ID: 16442629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced immunoprotective potential of Mycobacterium tuberculosis Ag85 complex protein based vaccine against airway Mycobacterium tuberculosis challenge following intranasal administration.
    Giri PK; Verma I; Khuller GK
    FEMS Immunol Med Microbiol; 2006 Jul; 47(2):233-41. PubMed ID: 16831210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of intranasal and subcutaneous route of immunization for development of mucosal vaccine against experimental tuberculosis.
    Giri PK; Sable SB; Verma I; Khuller GK
    FEMS Immunol Med Microbiol; 2005 Jul; 45(1):87-93. PubMed ID: 15985227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal vaccination with Mycobacterium bovis BCG: potential effects as a priming agent shown in a heterologous prime-boost immunization protocol.
    Rahman MJ; Fernández C
    Vaccine; 2009 Jun; 27(30):4038-46. PubMed ID: 19379788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal bacille Calmette-Guerin (BCG) vaccine dosage needs balancing between protection and lung pathology.
    Tree JA; Williams A; Clark S; Hall G; Marsh PD; Ivanyi J
    Clin Exp Immunol; 2004 Dec; 138(3):405-9. PubMed ID: 15544615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrapulmonary BCG cell wall vaccination in mice.
    Reuman PD; Ayoub EM
    Microbios; 1987; 49(198):7-15. PubMed ID: 3550393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
    Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
    J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
    Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
    Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
    Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of pulmonary DC function by vaccine-encoded GM-CSF enhances protective immunity against Mycobacterium tuberculosis infection.
    Nambiar JK; Ryan AA; Kong CU; Britton WJ; Triccas JA
    Eur J Immunol; 2010 Jan; 40(1):153-61. PubMed ID: 19830735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis.
    Aldwell FE; Cross ML; Fitzpatrick CE; Lambeth MR; de Lisle GW; Buddle BM
    Vaccine; 2006 Mar; 24(12):2071-8. PubMed ID: 16332403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node targeting of BCG vaccines amplifies CD4 and CD8 T-cell responses and protection against Mycobacterium tuberculosis.
    Waeckerle-Men Y; Bruffaerts N; Liang Y; Jurion F; Sander P; Kündig TM; Huygen K; Johansen P
    Vaccine; 2013 Feb; 31(7):1057-64. PubMed ID: 23273509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study of the protective effect of the DNA vaccine encoding tubercle antigen 85B with MPT64 in mice challenged with Mycobacterium tuberculosis].
    Luo XD; Zhu DY; Chen Q; Jiang Y; Jiang S; Yang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep; 27(9):611-6. PubMed ID: 15498274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
    Mollenkopf HJ; Kursar M; Kaufmann SH
    J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Mycobacterium bovis intranasal challenge model in mice.
    Logan KE; Gavier-Widen D; Hewinson RG; Hogarth PJ
    Tuberculosis (Edinb); 2008 Sep; 88(5):437-43. PubMed ID: 18590980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guérin.
    Ozeki Y; Hirayama Y; Takii T; Yamamoto S; Kobayashi K; Matsumoto S
    Vaccine; 2011 Sep; 29(40):6881-7. PubMed ID: 21803102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis.
    Chen L; Wang J; Zganiacz A; Xing Z
    Infect Immun; 2004 Jan; 72(1):238-46. PubMed ID: 14688101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with Single Oral Dose of Alginate-Encapsulated BCG Elicits Effective and Long-Lasting Mucosal Immune Responses.
    Hosseini M; Dobakhti F; Pakzad SR; Ajdary S
    Scand J Immunol; 2015 Dec; 82(6):489-97. PubMed ID: 26286252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.